Galaxy Biotech, LLC

Sunnyvale, CA 94089

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.49MM
First Award Date 08/16/05
Most Recent Award Date 09/01/12

Key Personnel

Last Name Name Awards Contact
Kim K Jin Kim 6

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/01/12 - 08/31/13
PI: K Jin Kim

DESCRIPTION (provided by applicant): The objective of the proposed research is to thoroughly characterize a humanized monoclonal antibody (mAb) that binds and inhibits human Fibroblast Growth Factor 2 (FGF2;basic FGF) for potential use in cancer therapy. FGF2 can directly stimulate tumor cell proliferation and also induces migration, proliferat...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 09/13/11 - 08/31/12
PI: K Jin Kim

DESCRIPTION (provided by applicant): The objective of the proposed research is to thoroughly characterize a humanized monoclonal antibody (mAb) that binds and inhibits human Fibroblast Growth Factor 2 (FGF2;basic FGF) for potential use in cancer therapy. FGF2 can directly stimulate tumor cell proliferation and also induces migration, proliferat...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 05/01/10 - 10/31/10
PI: K Jin Kim

DESCRIPTION (provided by applicant): The objective of the proposed research is to characterize a monoclonal antibody (mAb) that binds and blocks Fibroblast Growth Factor 2 (FGF2) for potential use in cancer therapy. The FGF family of growth factors is a large group of factors believed to play a role in the growth of many tumors, as well as in as...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 09/08/09 - 02/28/10
PI: K Jin Kim

DESCRIPTION (provided by applicant): The objective of the proposed research is to characterize monoclonal antibodies (mAbs) that bind and block the Fibroblast Growth Factor (FGF) Receptor 2 (FGFR2) for potential use in cancer therapy. The FGF family of growth factors is a large group of factors believed to play a role in the growth of many tumor...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/06 - 06/30/08
PI: K Jin Kim

DESCRIPTION (provided by applicant): The overall objective of the application is to perform necessary studies in preparation for conducting clinical trials in cancer of a humanized antibody that neutralizes hepatocyte growth factor (HGF). Previously, a novel mouse monoclonal antibody (mAb) L2G7 was generated that inhibits the ability of HGF to b...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/16/05 - 06/30/06
PI: K Jin Kim

DESCRIPTION (provided by applicant): The overall objective of the application is to perform necessary studies in preparation for conducting clinical trials in cancer of a humanized antibody that neutralizes hepatocyte growth factor (HGF). Previously, a novel mouse monoclonal antibody (mAb) L2G7 was generated that inhibits the ability of HGF to b...